当前蛋白身份:O14763 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验方法不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
1D0G CRYSTAL STRUCTURE OF DEATH RECEPTOR 5 (DR5) BOUND TO APO2L/TRAIL 提交 1999-09-09 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 R 54–183(130 aa) 片段:EXTRACELLULAR DOMAIN RESIDUES 1-130
链 S 54–183(130 aa) 片段:EXTRACELLULAR DOMAIN RESIDUES 1-130
链 T 54–183(130 aa) 片段:EXTRACELLULAR DOMAIN RESIDUES 1-130
未记录 ZN ZINC ION × 1 CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;292 K;15% Peg8K, 10% ethylene glycol, 0.2M ammonium sulface, 0.1M Tris-HCl, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 19K
分辨率 2.40 Å R-free 0.267
1DU3 Crystal structure of TRAIL-SDR5 提交 2000-01-14 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 54–183(130 aa) 片段:EXTRACELLULAR DOMAIN
链 B 54–183(130 aa) 片段:EXTRACELLULAR DOMAIN
链 C 54–183(130 aa) 片段:EXTRACELLULAR DOMAIN
未记录 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;pH 4.6;295 K;PEG 1000, Sodium Acetate, Sodium Chloride, pH 4.6, EVAPORATION, temperature 22K
分辨率 2.20 Å R-free 0.291
1DU3 Crystal structure of TRAIL-SDR5 提交 2000-01-14 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 G 54–183(130 aa) 片段:EXTRACELLULAR DOMAIN
链 H 54–183(130 aa) 片段:EXTRACELLULAR DOMAIN
链 I 54–183(130 aa) 片段:EXTRACELLULAR DOMAIN
未记录 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 EVAPORATION;pH 4.6;295 K;PEG 1000, Sodium Acetate, Sodium Chloride, pH 4.6, EVAPORATION, temperature 22K
分辨率 2.20 Å R-free 0.291
1ZA3 The crystal structure of the YSd1 Fab bound to DR5 提交 2005-04-05 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 S 54–183(130 aa) 片段:Extra-cellular domain
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.4;292 K;20% PEG 8000, 0.2M MgAcetate, 0.1M NaCacodylate pH 6.2-6.6, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 292K
分辨率 3.35 Å R-free 0.280
1ZA3 The crystal structure of the YSd1 Fab bound to DR5 提交 2005-04-05 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 R 54–183(130 aa) 片段:Extra-cellular domain
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.4;292 K;20% PEG 8000, 0.2M MgAcetate, 0.1M NaCacodylate pH 6.2-6.6, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 292K
分辨率 3.35 Å R-free 0.280
2H9G Crystal structure of phage derived Fab BdF1 with human Death Receptor 5 (DR5) 提交 2006-06-09 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 R 54–183(130 aa) 片段:extra cellular domain
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;292 K;Crystals from drops containing an equal volume of protein and well solution consisting of 20% PEG 3350, 0.2M Na2HPO4, 0.1 M Bis-Tris, pH 6.1-6.8. The crystals were cryo-protected with well solution supplemented with 20% PEG 200., pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K
分辨率 2.32 Å R-free 0.282
2H9G Crystal structure of phage derived Fab BdF1 with human Death Receptor 5 (DR5) 提交 2006-06-09 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 S 54–183(130 aa) 片段:extra cellular domain
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;292 K;Crystals from drops containing an equal volume of protein and well solution consisting of 20% PEG 3350, 0.2M Na2HPO4, 0.1 M Bis-Tris, pH 6.1-6.8. The crystals were cryo-protected with well solution supplemented with 20% PEG 200., pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K
分辨率 2.32 Å R-free 0.282
3X3F TRAIL-R2 Extracellular Region Complexed to a Fab fragment from Human Agonist Antibody KMTR2 提交 2015-01-20 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 54–184(131 aa) 片段:UNP residues 54-184
未记录 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 CL CHLORIDE ION × 1 GOL GLYCEROL × 5 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;7.5% PEG 3350, 75mM calcium chloride, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.10 Å R-free 0.224
4I9X Crystal structure of human cytomegalovirus glycoprotein UL141 targeting the death receptor TRAIL-R2 提交 2012-12-05 Assembly 1 其他组合 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 C 58–184(127 aa) 片段:TRAIL-R2, UNP residues 58-184
链 D 58–184(127 aa) 片段:TRAIL-R2, UNP residues 58-184
非标准单体:是(mmCIF未提供具体位点) 非标准单体:是(mmCIF未提供具体位点) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 CA CALCIUM ION × 4 NA SODIUM ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 9.5;295.15 K;20% PEG 8K, CHES, pH 9.5, VAPOR DIFFUSION, SITTING DROP, temperature 295.15K
分辨率 2.10 Å R-free 0.274
4N90 Crystal structure of ternary complex of TRAIL, DR5, and Fab fragment from a DR5 agonist antibody 提交 2013-10-18 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 T 57–182(126 aa) 片段:UNP residues 57-182
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;100 mM Tris pH 8.0, 1.0 M LiCl, 0.2 M MnCl2, 10% PEG6000, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 3.30 Å R-free 0.286
4N90 Crystal structure of ternary complex of TRAIL, DR5, and Fab fragment from a DR5 agonist antibody 提交 2013-10-18 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 S 57–182(126 aa) 片段:UNP residues 57-182
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;100 mM Tris pH 8.0, 1.0 M LiCl, 0.2 M MnCl2, 10% PEG6000, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 3.30 Å R-free 0.286
4N90 Crystal structure of ternary complex of TRAIL, DR5, and Fab fragment from a DR5 agonist antibody 提交 2013-10-18 Assembly 3 蛋白异源复合物 异源复合物;蛋白 × 4 PDB 声明:tetrameric(4) 与蛋白数一致
链 R 57–182(126 aa) 片段:UNP residues 57-182
未记录 ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;100 mM Tris pH 8.0, 1.0 M LiCl, 0.2 M MnCl2, 10% PEG6000, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 3.30 Å R-free 0.286
4OD2 Crystal structure of the Fab fragment of an anti-DR5 antibody bound to DR5 提交 2014-01-09 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 S 73–183(111 aa) 片段:UNP residues 73-183
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 8;292 K;Protein (7mg/mL in 20 mM Tris-HCl, 150 mM NaCl) was mixed with equal volume of well solution (30% PEG 4K, 0.1 M Tris-HCl pH 8.5, 0.2M MgCl2), VAPOR DIFFUSION, HANGING DROP, temperature 292K
分辨率 3.20 Å R-free 0.305
6NHW Structure of the transmembrane domain of the Death Receptor 5 - Dimer of Trimer 提交 2018-12-24 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 6 PDB 声明:hexameric(6) 与蛋白数一致
链 A 208–242(35 aa) 片段:residues 208-242
链 B 208–242(35 aa) 片段:residues 208-242
链 C 208–242(35 aa) 片段:residues 208-242
链 D 208–242(35 aa) 片段:residues 208-242
链 E 208–242(35 aa) 片段:residues 208-242
链 F 208–242(35 aa) 片段:residues 208-242
未记录 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 7;303 K;离子强度(mmCIF原始值)50;压力 1
NMR样品组成 0.8 mM [U-13C; U-15N; 85%-2H] Transmembrane Domain of Death Receptor 5, 50 mM DMPC, 100 mM DHPC, 20 mM sodium phosphate, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR样品组成 0.8 mM [U-13C; U-15N] Transmembrane Domain of Death Receptor 5, 50 mM [acyl chain U-2H] DMPC, 100 mM [acyl chain U-2H] DHPC, 20 mM sodium phosphate, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR样品组成 0.4 mM [U-15N; U-2H; 15%-13C] Transmembrane Domain of Death Receptor 5, 50 mM [acyl chain U-2H] DMPC, 100 mM [acyl chain U-2H] DHPC, 20 mM sodium phosphate, 95% H2O/5% D2O | 95% H2O/5% D2O
分辨率未提供
6NHY Structure of the transmembrane domain of the Death Receptor 5 mutant (G217Y) - Trimer Only 提交 2018-12-24 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 208–242(35 aa)
链 B 208–242(35 aa)
链 C 208–242(35 aa)
突变:G217Y 突变:G217Y 突变:G217Y 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 7;303 K;离子强度(mmCIF原始值)50;压力 1
NMR样品组成 0.8 mM [U-13C; U-15N; 85%-2H] Transmembrane Domain of DR5 Mutant G217Y, 50 mM DMPC, 100 mM DHPC, 20 mM sodium phosphate, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR样品组成 0.8 mM [U-13C; U-15N] Transmembrane Domain of DR5 Mutant G217Y, 50 mM [acyl chain U-2H] DMPC, 100 mM [acyl chain U-2H] DHPC, 20 mM sodium phosphate, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR样品组成 0.4 mM [15%-13C; U-15N; H-2H] Transmembrane Domain of DR5 Mutant G217Y, 50 mM [acyl chain U-2H] DMPC, 100 mM [acyl chain U-2H] DHPC, 20 mM sodium phosphate, 95% H2O/5% D2O | 95% H2O/5% D2O
分辨率未提供
6T3J Dual Epitope Targeting by Anti-DR5 Antibodies 提交 2019-10-11 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 E 58–184(127 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.6;281 K;10% (w/v) PEG 4000 200 mM ammonium sulphate 100 mM Sodium acetate pH 4.6
分辨率 3.05 Å R-free 0.282
6T3J Dual Epitope Targeting by Anti-DR5 Antibodies 提交 2019-10-11 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 5 PDB 声明:pentameric(5) 与蛋白数一致
链 J 58–184(127 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 4.6;281 K;10% (w/v) PEG 4000 200 mM ammonium sulphate 100 mM Sodium acetate pH 4.6
分辨率 3.05 Å R-free 0.282
8DPX Preligand association structure of DR5 提交 2022-07-17 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 77–184(108 aa)
链 B 77–184(108 aa)
链 C 77–184(108 aa)
未记录 未记录非水小分子 SOLUTION NMR
NMR测量条件 pH 7.2;310 K;离子强度(mmCIF原始值)50;压力 1
NMR样品组成 400 uM [U-100% 15N, U-100% 13C, U-85% 2H] DR5 ectodomain, 4.4 mM DGS-NTA (Ni), 44 mM DMPC, 88 mM D7PC, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR样品组成 500 uM [U-100% 15N; U-100% 2H] DR5 ectodomain, 5.5 mM DGS-NTA (Ni), 55 mM DMPC, 110 mM D7PC, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR样品组成 250 uM [U-100% 15N; U-100% 2H] Isotopically mixed DR5 ectodomain, 250 uM [U-100% 13C] DR5 ectodomain, 5.5 mM DGS-NTA (Ni), 55 mM DMPC, 110 mM D7PC, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR样品组成 250 uM [U-100% 13C; U-100% 15N; U-95% 2H] Isotopically mixed DR5 ectodomain, 250 uM DR5 ectodomain, 5.5 mM DGS-NTA (Ni), 55 mM DMPC, 110 mM D7PC, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR样品组成 500 uM [U-100% 13C; U-100% 15N] DR5 ectodomain, 5.5 mM DGS-NTA (Ni), 55 mM DMPC, 110 mM D7PC, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR样品组成 400 uM [U-100% 15N, U-85% 2H] DR5 ectodomain, 4.4 mM DGS-NTA (Ni), 44 mM DMPC, 88 mM D7PC, 95% H2O/5% D2O | 95% H2O/5% D2O
分辨率未提供